424B3: Prospectus filed pursuant to Rule 424(b)(3)
Published on November 4, 2009
Filed
pursuant to Rule 424(b)(3)
File
No. 333-143263
Prospectus
Supplement No. 4
(To
Prospectus dated April 27, 2009)
NOVELOS
THERAPEUTICS, INC.
12,000,000
shares of common stock
This
prospectus supplement supplements the Prospectus dated April 27, 2009, relating
to the resale of 12,000,000 shares of our common stock. This
prospectus supplement should be read in conjunction with the
Prospectus.
RESULTS
OF SPECIAL MEETING OF SHAREHOLDERS
On
November 3, 3009, we held a special meeting in lieu of annual meeting of
stockholders. At the meeting, our stockholders approved an amendment
to our certificate of incorporation to increase the total number of authorized
shares of our common stock by 75 million shares, from 150 million to 225
million. Following the adjournment of the meeting, we filed the
amendment with the Secretary of State of Delaware, and it went into effect on
November 3, 2009.
In
addition to the approval of the amendment of our certificate of incorporation as
described above, our stockholders re-elected each incumbent member of our board
of directors and approved an amendment to our 2006 Stock Incentive Plan to
increase the shares of common stock authorized under the plan by 5 million
shares, from 5 million to 10 million. The amendment to the 2006 Stock
Incentive Plan became effective immediately upon its approval by our
stockholders.
Investing
in our common stock involves a high degree of risk.
See
Risk Factors beginning on page 7 of the Prospectus.
Neither the Securities and Exchange Commission nor any state
securities commission has approved or
disapproved of these securities or passed on the adequacy or
accuracy of this prospectus supplement. Any
representation to the contrary is a criminal offense.
The date
of this prospectus supplement is November 4, 2009